Efficacy and Safety of Timolol for TKI Induced Paronychia
Condition(s):ParonychiaLast Updated:December 20, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):ParonychiaLast Updated:December 20, 2023Recruiting
Condition(s):HemangiomaLast Updated:November 2, 2023Recruiting
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:May 12, 2023Recruiting
Condition(s):Acne Scars – Mixed Atrophic and HypertrophicLast Updated:February 21, 2023Not yet recruiting
Condition(s):Cataract; Glaucoma; Ocular HypertensionLast Updated:November 13, 2023Recruiting
Condition(s):Primary Open-angle GlaucomaLast Updated:March 25, 2024Recruiting
Condition(s):Glaucoma Open-Angle Primary; Ocular HypertensionLast Updated:February 14, 2024Recruiting
Condition(s):Open Angle Glaucoma, Ocular HypertensionLast Updated:February 9, 2023Recruiting
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:December 6, 2023Recruiting
Condition(s):Glaucoma; OHT – Ocular HypertensionLast Updated:January 19, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.